Healthcare company Healius (ASX:HLS) changed the terms of employment of Chief Executive Officer Paul Anderson, according to a Monday filing with the Australian bourse.
The CEO's tenure will now move to "permanent ongoing employment, subject to termination," from a fixed term ending June 30, 2026.
Anderson's fixed annual remuneration will also be increased to AU$1.3 million from AU$1.1 million, effective Jan. 1.
Further, the CEO's fiscal year 2027 bonus arrangements will include short- and long-term incentives to align with the remuneration structure for other key management personnel, pending performance measures, the filing said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。